Found: 13
Select item for more details and to access through your institution.
MicroRNAs as Mediators of Resistance Mechanisms to Small-Molecule Tyrosine Kinase Inhibitors in Solid Tumours.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Therapies Targeting the Tumor Stroma and the VEGF/VEGFR Axis in Pancreatic Ductal Adenocarcinoma: a Systematic Review and Meta-Analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Niraparib: A Review in Ovarian Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Coronary Toxicities of Anti-PD-1 and Anti-PD-L1 Immunotherapies: a Case Report and Review of the Literature and International Registries.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Inotuzumab Ozogamicin: A Review in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The Role of Autophagy in the Resistance to BRAF Inhibition in BRAF-Mutated Melanoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Preparation of Folic Acid-Targeted Temperature-Sensitive Magnetoliposomes and their Antitumor Effects In Vitro and In Vivo.
- Published in:
- 2018
- By:
- Publication type:
- journal article
BIM Deletion Polymorphism Confers Resistance to Osimertinib in EGFR T790M Lung Cancer: a Case Report and Literature Review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Targeted Next-Generation Sequencing in Men with Metastatic Prostate Cancer: a Pilot Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Growing Role of Regorafenib in the Treatment of Patients with Sarcoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Low-Dose Continuous 5-Fluorouracil Combined with Leucovorin, nab-Paclitaxel, Oxaliplatin, and Bevacizumab for Patients with Advanced Pancreatic Cancer: A Retrospective Analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article